ENHANCEMENT OF IMMUNE RESPONSES MEDIATED BY PROTEINS FUSED FROM ANTIBODY AND CYTOKINE BY METHOD OF COMBINED ADMINISTRATION OF ANGIOGENESIS INHIBITOR Russian patent published in 2004 - IPC

Abstract RU 2229305 C2

FIELD: medicine, immunology. SUBSTANCE: invention reports about compositions and methods for enhancement of cytocide immune responses directed against preliminary taken cells type in mammals. Methods and compositions are based on the combination of immunoconjugate of type antibody-cytokine and angiogenesis inhibitor. In administration to mammal the immunoconjugate induces the response against preliminary taken cells type, for example, cancer cells that as result of synergetic effect with angiogenesis inhibitor exceeds the immune response induced by a single immunoconjugate. Methods and compositions are useful especially for eradication solid tumors or virus-infected mammalian cells. EFFECT: expanded assortment of immunomodulating agents. 27 cl, 5 dwg

Similar patents RU2229305C2

Title Year Author Number
ENHANCEMENT OF IMMUNE RESPONSE WHEREIN FUSED PROTEIN ANTIBODY-CYTOKINE IS MEDIATOR BY COMBINED TREATMENT WITH AGENTS INCREASING IMMUNOCYTOKINE ABSORPTION 2001
  • Gilliz Stiven D.
  • Lan' Jan'
  • Kholden Sil'Vija A.
RU2272644C2
HOMODIMERIC FUSED PROTEIN WITH ACTIVITY OF ANGIOGENESIS INHIBITOR (VARIANTS), DNA MOLECULE ENCODING HOMODIMERIC FUSED PROTEIN, VECTOR FOR EXPRESSION OF HOMODIMERIC FUSED PROTEIN, METHOD FOR TRANSFECTION OF MAMMALIAN CELL AND METHOD FOR PREPARING HOMODIMERIC FUSED PROTEIN 1999
  • Lo Kin-Ming
  • Li Jue
  • Dzhilliz Stefen D.
RU2240328C2
HUMANISED ANTIBODY (H14,18) BASED ON MOUSE ANTIBODY 14,18, CONTACTING GD2, AND ITS FUSION WITH IL-2 2003
  • Dzhilliz Stefen D.
  • Lo Kin Ming
RU2366664C2
FUSED PROTEINS WITH IMMUNOGLOBULIN FC-FRAGMENT FOR ENHANCING IMMUNOGENICITY OF PROTEIN AND PEPTIDE ANTIGENS 2000
  • Dzhilliz Stefen D.
  • Lo Kin Ming
  • Vesolovski Dzhon S. Dzhr.
RU2248214C2
NRR Notch1 ANTIBODIES AND METHODS OF APPLICATION THEREOF 2008
  • Sibel Kristian V.
  • U Jan'
RU2476443C2
ANTIBODIES AGAINST VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) 2008
  • Fa Zhermejn
  • Li Chingvehj V.
RU2514148C2
HUMAN MONOCLONAL ANTIBODIES AGAINST PROGRAMMED DEATH 1 (PD-1) PROTEIN AND CANCER TREATMENT METHOD USING ANTI-PD-1-ANTIBODIES SEPARATELY OR COMBINED WITH OTHER IMMUNOTHERAPEUTIC AGENTS 2013
  • Korman Alan Dzh.
  • Srinivasan Mokhan
  • Van Chanyuj
  • Selbi Mark Dzh.
  • Chen Bin
  • Kardarelli Zhozefin M.
RU2599417C2
IMMUNOCONJUGATES, PREPARATION METHOD, AND PHARMACEUTICAL COMPOSITION 1995
  • Vol'Fgang Khel'Tser
  • Ilka Fon Khoegen
  • Vol'Fgang Shtrittmatter
  • Zigfrid Mattsku
RU2157701C2
EGFL7 ANTIBODIES AND METHODS OF APPLICATION THEREOF 2007
  • E Vehjlan'
  • Shmidt Majke
  • Khongo Dzho-Ehnn
  • U Jan'
RU2415870C2
HUMAN MONOCLONAL ANTIBODIES SPECIFIC FOR PROGRAMMED CELL DEATH 1 (PD1) PROTEIN AND METHODS OF TREATING CANCER WITH USING ANTI-PD1 ANTIBODIES EITHER INDIVIDUALLY, OR IN COMBINATION WITH OTHER IMMUNOTHERAPEUTIC AGENTS 2006
  • Korman Alan Dzh.
  • Srinivasan Mokhan
  • Van Chanjuj
  • Selbi Mark Dzh.
  • Chehn' Bin
  • Kardarelli Zhozefin M.
  • Khuan Khajchun'
RU2494107C2

RU 2 229 305 C2

Authors

Dzhilliz Stefen D.

Dates

2004-05-27Published

1999-04-15Filed